康拓医疗(688314)每日收评(06-26)

Group 1 - The stock of Kangtuo Medical (688314) has a comprehensive score of 47.79, indicating a weak performance [1] - The main cost analysis shows the following prices: current main cost at 29.70 yuan, 5-day main cost at 29.24 yuan, 20-day main cost at 30.09 yuan, and 60-day main cost at 29.18 yuan [1] - Over the past year, the stock has not experienced any limit-up or limit-down events [1] Group 2 - The short-term pressure level is at 29.63 yuan, while the short-term support level is at 28.33 yuan [2] - The stock price has the potential to strengthen in the short term if it breaks through the short-term pressure level, but the mid-term trend remains unclear [2] - The K-line pattern indicates heavy pressure at the upper levels, with a long upper shadow suggesting resistance, while the "red three soldiers" pattern indicates a possible bottoming out and recovery [2] Group 3 - On June 26, 2025, the net inflow of main funds was 160.69 thousand yuan, accounting for 6% of the total transaction amount [2] - There was no net inflow from super large orders, while large orders contributed a net inflow of 160.69 thousand yuan, and retail investors saw a net inflow of 62.30 thousand yuan [2] - Related industry sectors showed mixed performance, with medical devices down by 0.55% and the medical device concept down by 0.46% [2]